KPMG can help you improve the ROI on your sales investments - helping you manage winning sales strategies, processes, and talent with connected insights.
By Alex Tolmasoff, Director, KPMG Sales Transformation and HCLS Lead
Have you ever wondered where and how high-performance providers are investing in technology to counter the impact of the last few years?
Recent KPMG research indicates that those healthcare providers leading the way are doing so through technology investments, focusing specifically on patient engagement.1
- High growth providers spent nearly 3% more on technology 2021-2022 than low / no growth counterparts
- High performance providers will spend over 40% more than other providers in 2023 on Electronic Health Record (EHR) upgrades and patient portals / scheduling software
The COVID-19 pandemic had an unprecedented effect on patients and healthcare providers; to understand the impact and aftereffects on healthcare organizations and how the front office (particularly the sales organization) must retool itself for this “new normal”, KPMG surveyed nearly 100 providers, including surgeons, primary care physicians, and hospital C-suite leaders in mid-2022. The survey set out to gauge provider perspectives in three key areas:
- Expectations on a return to normal, and how budgets have been impacted
- How technology will shape future operations in light of COVID impacts
- How vendor relationships will shift to accommodate new ways of working
In a series of blogs exploring the survey findings, I continue here by concentrating on:
- How technology investment, and a strategic two-stage approach is separating high performance providers from laggards
- The importance of telehealth and training